Skip to main content
Clinical Trials/ISRCTN86160989
ISRCTN86160989
Completed
N/A

A pre-post intervention study to investigate the effectiveness of diabetes specific online therapist delivered cognitive behavioural therapy for patients with Type 2 diabetes and with a comorbid axis I disorder

Roche Diabetes Care Ltd0 sites102 target enrollmentOctober 22, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Type 2 Diabetes with co-morbid anxiety disorder and/or depression
Sponsor
Roche Diabetes Care Ltd
Enrollment
102
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 22, 2018
End Date
July 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Roche Diabetes Care Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 18 years or older
  • 2\. Diagnosed with type 2 diabetes at least 12 months prior
  • 3\. Co\-morbid anxiety disorder and/or depression

Exclusion Criteria

  • 1\. Unsuitable for cognitive behavioural therapy
  • 2\. Unable to access an Internet\-enabled device or no access to an Internet connection
  • 3\. Low level of literacy
  • 4\. Visually impaired and unable to write on or read from a computer, and unable to access appropriate assistive technology for the visually impaired
  • 5\. Unable to speak English
  • 6\. Unsuitable for treatment within a primary care psychological therapy service:
  • 6\.1\. Patients who become actively suicidal or present as a risk to others will be referred to a more specialised, secondary care service
  • 6\.2\. Patients experiencing symptoms of psychosis, hypermania, severe cognitive impairment, severe personality disorders or a severe learning disability are also unsuitable for the study and will be referred to more specialised services
  • 7\. Already involved in a different research project
  • 8\. Undergoing any other mental health therapy at present

Outcomes

Primary Outcomes

Not specified

Similar Trials